Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liquid biopsies to monitor and direct cancer treatment in colorectal cancer
Gianluca Mauri, Pietro Paolo Vitiello, Alberto Sogari, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 3, pp. 394-407
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer
Vincenza Caputo, Fortunato Ciardiello, Carminia M. Della Corte, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 102-138
Open Access | Times Cited: 36
Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine
Ying Bao, Dejing Zhang, Huihui� Guo, et al.
Cancer Science (2024) Vol. 115, Iss. 4, pp. 1060-1072
Open Access | Times Cited: 15
Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers
Deborah Wenk, Charlotte Zuo, Thomas Kislinger, et al.
Clinical Proteomics (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)
Mohamed A. Gouda, Filip Janků, Adam Wahida, et al.
Annals of Oncology (2023) Vol. 35, Iss. 3, pp. 267-275
Open Access | Times Cited: 29
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer
Davide Ciardiello, Erika Martinelli, Teresa Troiani, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e245635-e245635
Open Access | Times Cited: 11
Incorporating Novel Technologies in Precision Oncology for Colorectal Cancer: Advancing Personalized Medicine
Pankaj Ahluwalia, Kalyani Ballur, Tiffanie Leeman, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 480-480
Open Access | Times Cited: 10
The role of anti-EGFR rechallenge in metastatic colorectal cancer, from available data to future developments: A systematic review
Davide Ciardiello, Gianluca Mauri, Andrea Sartore‐Bianchi, et al.
Cancer Treatment Reviews (2024) Vol. 124, pp. 102683-102683
Closed Access | Times Cited: 6
Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer
Laura Roazzi, Giorgio Patelli, Katia Bencardino, et al.
Clinical Colorectal Cancer (2024) Vol. 23, Iss. 4, pp. 295-308
Closed Access | Times Cited: 6
The clinical utility of circulating human papillomavirus across squamous cell carcinomas
Karen‐Lise Garm Spindler, Anne Vagner Jakobsen, Jesper Grau Eriksen, et al.
Acta Oncologica (2025) Vol. 64, pp. 1-12
Open Access
Health Economic Evaluations of Circulating Tumor DNA Testing for Cancer Screening: Systematic Review
Mingjun Rui, Yingcheng Wang, Joyce H. S. You
Cancer Medicine (2025) Vol. 14, Iss. 3
Open Access
Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications
Olivia Vandekerckhove, Kristof Cuppens, Karin Pat, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2702-2702
Open Access | Times Cited: 15
Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding road
Alejandro Ríos-Hoyo, Xavier Monzonís, Joana Vidal, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells
Iris van ‘t Erve, Jamie E. Medina, Alessandro Leal, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 5, pp. 899-909
Open Access | Times Cited: 23
Horizontal Transfer of Malignant Traits and the Involvement of Extracellular Vesicles in Metastasis
Goffredo Arena, Stefano Forte, Mohamed Abdouh, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1566-1566
Open Access | Times Cited: 13
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer
Giorgio Patelli, Gianluca Mauri, Federica Tosi, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 22, pp. 4530-4539
Open Access | Times Cited: 13
The prognostic potential of CDX2 in colorectal cancer: Harmonizing biology and clinical practice
Jordi Badia-Ramentol, Francisco Gimeno-Valiente, E. Durendez-Saez, et al.
Cancer Treatment Reviews (2023) Vol. 121, pp. 102643-102643
Open Access | Times Cited: 12
An update on pharmacotherapies for colorectal cancer: 2023 and beyond
Mengou Zhu, Al B. Benson
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 1, pp. 91-99
Closed Access | Times Cited: 4
Molecular methods for colorectal cancer screening: Progress with next-generation sequencing evolution
Salma Abbes, Simone Baldi, Hayet Sellami, et al.
World Journal of Gastrointestinal Oncology (2023) Vol. 15, Iss. 3, pp. 425-442
Open Access | Times Cited: 11
Current status of locally advanced rectal cancer therapy and future prospects
Ioannis M. Koukourakis, Vassilis Kouloulias, Dina Tiniakos, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 186, pp. 103992-103992
Closed Access | Times Cited: 11
Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?
Sheefa Mirza, Kinjal Bhadresha, Muhammad Jameel, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 9
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer
Astrid Kramer, Marjolein J.E. Greuter, Suzanna J. Schraa, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF wild type metastatic colorectal cancer in the CAPRI 2-GOIM trial
D. Ciardiello, Luca Boscolo Bielo, S. Napolitano, et al.
Annals of Oncology (2024)
Closed Access | Times Cited: 2
NTRK fusions in thyroid cancer: Pathology and clinical aspects
Yanhui Ma, Qi Zhang, Kexin Zhang, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 184, pp. 103957-103957
Closed Access | Times Cited: 7
Deciphering the Clinical Significance and Kinase Functions of GSK3α in Colon Cancer by Proteomics and Phosphoproteomics
Li Gao, Ying Lü, Hai‐Ning Chen, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 5, pp. 100545-100545
Open Access | Times Cited: 7
A deep learning approach for the detection and counting of colon cancer cells (HT-29 cells) bunches and impurities
Inayatul Haq, Tehseen Mazhar, Rizwana Naz Asif, et al.
PeerJ Computer Science (2023) Vol. 9, pp. e1651-e1651
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top